Rice Hall James & Associates’s Tandem Diabetes Care TNDM Stock Holding History

Rice Hall James & Associates’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-72,878	Closed	-$1.4M	–	254
2026 Q1	$1.4M	Buy	72,878 +10,463	+17%	+$227K	0.08%	189
2025 Q4	$1.37M	Sell	62,415 -40,154	-39%	-$725K	0.08%	184
2025 Q3	$1.25M	Sell	102,569 -1,385	-1%	-$18.7K	0.07%	191
2025 Q2	$1.94M	Sell	103,954 -1,002	-1%	-$19.8K	0.1%	164
2025 Q1	$2.01M	Sell	104,956 -526	-0.5%	-$15.4K	0.12%	158
2024 Q4	$3.8M	Buy	105,482 +13,224	+14%	+$447K	0.21%	111
2024 Q3	$3.91M	Sell	92,258 -1,035	-1%	-$43.9K	0.21%	105
2024 Q2	$3.76M	Sell	93,293 -847	-0.9%	-$35.3K	0.23%	102
2024 Q1	$3.33M	Sell	94,140 -10,290	-10%	-$276K	0.19%	114
2023 Q4	$3.09M	Sell	104,430 -2,946	-3%	-$61.1K	0.18%	124
2023 Q3	$2.23M	Buy	+107,376	New	+$2.95M	0.14%	162

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Rice Hall James & Associates's TNDM Position: Q2 2026 in Review

Rice Hall James & Associates sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 72,878 shares — an estimated $1.4M sold.

Rice Hall James & Associates first reported a position in TNDM in Q3 2023 and held it in 11 quarters. The position peaked at $3.91M in Q3 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Rice Hall James & Associates reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
Rice Hall James & Associates sold 72,878 Tandem Diabetes Care shares in Q2 2026, an estimated $1.4M.
Rice Hall James & Associates first reported a position in Tandem Diabetes Care in Q3 2023 and held it in 11 quarters.
Rice Hall James & Associates's Tandem Diabetes Care position peaked at $3.91M in Q3 2024.
273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.